The construction and analysis of ceRNA and tumor-infiltrating immune cell networks in the distant metastasis of lung adenocarcinoma

Author:

liu Jun1,zhu Yun2,Guo Yuntao2,Tang Shuainan2,Fu Guolong2,Zhang Tongsong3,Song Haiping4,Zhao Dezhi5,Wang Licheng6,Jiang Xin2

Affiliation:

1. Bengbu Third People's Hospital ,Anhui

2. Medical Laboratory of Nantong Zhongke

3. Qingdao Tumor Hospital

4. Qingdao Central Hospital

5. 6Guo Chen Medical Technology Co

6. Second Hospital of Heilongjiang Province

Abstract

Abstract Lung adenocarcinoma (LUAD) is the most common lung cancer with a high rate of distant metastasis. The potential mechanism of competitive endogenous RNA (ceRNA) and tumor-infiltrating immune cells in LUAD distant metastasis is still unclear. RNA profiles of LUAD were downloaded from the cancer genome atlas (TCGA) including primary LUADs without or with distant metastasis. The miRNA-mRNA and lncRNA-miRNA interaction information were downloaded to establish the distant metastasis-specific ceRNA network. The algorithm “cell type identification by estimating relative subsets of RNA transcripts (CIBERSORT)” was used to estimate their immune cells. The Pearson correlation analysis was utilized to compare the prognostic biomarker in the ceRNA network and immune cell proportion. We established the two nomograms of metastasis-related ceRNA networks and immune cells. The Receiver Operating Characteristic (ROC) and the calibration curves indicated acceptable accuracy and discrimination of the nomogram. Based on the correction analysis between metastasis-related ceRNA and immune cells, along with external validation, NR3C2, PIK3R1, PTPN13, SPRY2 and mast cells resting were found to be associated with each other and constitute the potential regulation networks. Our data identify prognostic ceRNAs and immune cells and provide two prediction nomograms. Besides, the potential regulatory networks among NR3C2, PIK3R1, PTPN13, SPRY2 and mast cells resting are also uncovered, which may take part in the distant metastasis of LUAD.

Publisher

Research Square Platform LLC

Reference44 articles.

1. Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis;Leal TA;Current medical research and opinion,2020

2. Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers;Chambard L;Bone,2018

3. Overexpressed BSG related to the progression of lung adenocarcinoma with high-throughput data-mining, immunohistochemistry, validation and investigation;WT H;American journal of translational research,2019

4. Metabolomic, transcriptomic and genetic integrative analysis reveals important roles of adenosine diphosphate in haemostasis and platelet activation in non-small-cell lung cancer;LT H;Molecular oncology,2019

5. Huang Z, Tong Y, Tian H and Zhao C: Establishment of a prognostic nomogram for lung adenocarcinoma with brain metastases. World neurosurgery, 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3